/Investor DB

Gron Ventures, Llc — Full Portfolio

4 tracked investments · listed companies and verified rows first

Dutchiedutchie.comin𝕏Jan 2024 · $100M

Dutchie operates an online marketplace connecting consumers with cannabis dispensaries across North America, offering real-time menus, order-ahead pickup, and delivery.

E-commerceMarketplacesRetail Tech

Zach Lipson(Founder)inRoss Lipson(Founder)Ross Lipson Zach Lipson(Founder)

Co-investorsCasa Verde CapitalGlynn Capital ManagementLevel One FundSinai Capital PartnersTidemarkVine Ventures+6 more

FLOWER CO.flowercompany.comin𝕏Series A

The Flower Company offers on-demand cannabis delivery, providing flower and concentrates to medical and recreational users.

ConsumerE-commerceMarketplacesLos Angeles, US

Scott Davies(Chief Strategy Officer (CSO))inTed Lichtenberger(Founder)inChad Powell(Vice President Product and Growth)inTony DiepenbrockTamara Leonard(Senior Technical Recruiter)

Co-investorsArtemis Growth PartnersFlying Tiger CapitalService Provider CapitalVU Venture PartnersY CombinatorAccess X+8 more

Gilgamesh Pharmaceuticalsgilgameshpharmaceutical.comin𝕏Series A · Dec 2022 · $39M

Gilgamesh Pharmaceutical develops novel chemical entities for psychiatric disorders using medicinal chemistry and AI-powered translational platforms to design rapid-acting therapies targeting neurobiological mechanisms rather than symptom management.

AI & Machine LearningBiotechDigital HealthHealthtechNew York City, US

Jonathan Sporn(Founder)inAndrew Kruegel(Founder)inDalibor Sames(Founder)inAndrew Kruegel, Ph.D.(Executive Officer)Thomas Kevin Murphy, Ph.D.(Executive Officer)JONATHAN SPORN(Founder)in

Co-investorsAera VCAlumni VenturesAwareness VentureFrontera Technology VenturesFrontier Path VCGaingels+26 more

Rev Genomicsrevgenomics.cominSeries A · Apr 2019

Rev Genomics uses genomic selection, tissue culture, and molecular analysis to develop high-value crop cultivars for breeders and seed banks.

AgTechBiotechHealthtechMedical DevicesSan Francisco, US

Bertrand Vick(CEO)inRobert John Markelz(Executive Officer, Director, Promoter)Gloria E Webster(Director, Promoter)Robert Markelz(Vice President of Genomics)

Co-investorsY CombinatorMerida Capital HoldingsAdditionAgrolimen VenturesFloret VenturesL4 Inc.+3 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.